Professor Choi Hee-jung as the new chairman of the Korean Infectious Society...Focus on revitalizing academic research on infectious diseases
Dec 04, 2025
Choi Hee-jung, a professor of infectious diseases at Ewha Womans University Mokdong Hospital, was inaugurated as the 33rd president of the Korean Infectious Society. The term of office is two years from December 2025, and the new chairman was Kim Hong-bin, a professor of infectious diseases at Bundang Seoul National University Hospital.
Professor Choi Hee-jung is an authority in the field of infectious disease treatment, and he is the vice chairman and insurance director of the Korean Society of AIDS, the auditor and general director of the Korean Society of Chemotherapy, the law director, the executive director, the insurance director, and the Korea AntimicrobialVarious academic activities were carried out, including the audit of the Law Society, the legal director of the Korean Medical Association, and the academic director of the Korean Hospital Infection Control Association.
In particular, he has been steadily conducting research on infection control, antibiotic treatment, and vaccination in operating rooms and intensive care units, and has also participated in writing related papers several times. He is currently serving as the head of the strategic planning division of Ewha Womans University Medical Center.
In addition, Professor Choi Hee-jung received a commendation from the Seoul mayor in 2016 in recognition of his contribution to quarantine activities during the MERS outbreak and received a commendation from the Minister of Health and Welfare for the infectious disease monitoring project.
Professor Choi Hee-jung said, `New infectious diseases such as swine flu in 2009, MERS in 2015, and COVID-19 in 2020 are showing a periodic occurrence. In order to effectively respond to the upcoming new infectious diseases, it is important to thoroughly prepare through in-depth research. "Since the Korean Infectious Society is an authoritative organization that provides an academic basis for the treatment of infectious diseases, we will focus on revitalizing academic research and strive to create an environment in which infectious experts can be nurtured and professionalized.'
Professor Choi Hee-jung is an authority in the field of infectious disease treatment, and he is the vice chairman and insurance director of the Korean Society of AIDS, the auditor and general director of the Korean Society of Chemotherapy, the law director, the executive director, the insurance director, and the Korea AntimicrobialVarious academic activities were carried out, including the audit of the Law Society, the legal director of the Korean Medical Association, and the academic director of the Korean Hospital Infection Control Association.
In particular, he has been steadily conducting research on infection control, antibiotic treatment, and vaccination in operating rooms and intensive care units, and has also participated in writing related papers several times. He is currently serving as the head of the strategic planning division of Ewha Womans University Medical Center.
In addition, Professor Choi Hee-jung received a commendation from the Seoul mayor in 2016 in recognition of his contribution to quarantine activities during the MERS outbreak and received a commendation from the Minister of Health and Welfare for the infectious disease monitoring project.
Professor Choi Hee-jung said, `New infectious diseases such as swine flu in 2009, MERS in 2015, and COVID-19 in 2020 are showing a periodic occurrence. In order to effectively respond to the upcoming new infectious diseases, it is important to thoroughly prepare through in-depth research. "Since the Korean Infectious Society is an authoritative organization that provides an academic basis for the treatment of infectious diseases, we will focus on revitalizing academic research and strive to create an environment in which infectious experts can be nurtured and professionalized.'
|
This article was translated by Naver AI translator.
